A group of U.S. senators is digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this year in search of any indication the services could create conflicts of ...

"Slim Aarons: Gold Coast," an exhibition that highlights Aarons' years of work in Palm Beach and how that work intertwined with Palm Beach icon Lilly Pulitzer, kicks off the Ann Norton Sculpture ...

“Some simple yet impactful décor ideas bring in the spirit of Diwali while keeping sustainability at the forefront, proving that conscious design can be as beautiful as it is responsible ...

It provided little detail other than saying that Eli Lilly had shown it could “meet the present and projected national demand,” while acknowledging that patients could still see periodic ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best medical stocks to buy now. The medical and healthcare industry is one of the ...

Over the last couple of years, pharmaceutical giant Eli Lilly (NYSE: LLY) has made a splash in the red-hot weight loss space. The company's path-breaking innovation in using glucagon-like peptide ...

Distinguished by contemporary design and construction flexibility, these products promote an architectural future grounded in harmony between the natural and the built environment. This approach ...

But it was Lilly’s story, as a trailblazer in the fight for equal pay, that captivated all of us in the room that day, as it has captivated so many over the years. Lilly, who died this weekend ...

Whether you're a fall fanatic or passionate about Halloween decor, pumpkins are the go-to gourd for adding a festive and timeless look all season long. While many opt to carve jack-o'-lanterns ...

Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...

Eli Lilly has brought in billion-dollar revenue from its weight loss drugs -- but short supply has limited the revenue opportunity. The FDA earlier this month recognized Lilly’s progress in ...